Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | News
Search Refinements

Contract Research News

View news from other Pharmaceutical sectors:
106-120 of 2107 results
US researchers re-engineer CRISPR-Cas9 system to minimize gene editing errors
Researchers at the Broad Institute of MIT and Harvard and the McGovern Institute for Brain Research at MIT have re-engineered the CRISPR-Cas9 genome system to minimize gene editing errors.
Contract Research & Services > Contract Research > News
Children’s cancer death rates drop by 24% in last decade
The rate of children dying from cancer has dropped by 24% in the last decade, according to new figures published by Cancer Research UK.
Contract Research & Services > Contract Research > News
Brickell Biotech secures rights to ROR gamma inhibitors for psoriasis
By PBR Staff Writer
Brickell Biotech has secured the exclusive global rights to a series of novel retinoic acid–related orphan nuclear receptor gamma (RORγ) inhibitors from Orca Pharmaceuticals and New York University.
Contract Research & Services > Contract Research > News
LSP, Bristol-Myers Squibb partner to work on immuno-oncology innovation in Europe
By PBR Staff Writer
Life Sciences Partners (LSP) and Bristol-Myers Squibb have collaborated to find out European breakthrough technologies and products in immuno-oncology and other areas.
Contract Research & Services > Contract Research > News
Lilly, Merck extend immuno-oncology collaboration
Eli Lilly and Company and Merck have extended their immuno-oncology collaboration with Phase III nonsquamous non-small cell lung cancer trial (NSCLC).
Contract Research & Services > Contract Research > News
Servier exercises option to buy rights to Cellectis' UCART19 immunotherapy candidate
By PBR Staff Writer
Servier has exercised its option with Cellectis to acquire exclusive worldwide rights to UCART19, a TALEN gene-edited allogeneic chimeric antigen receptor T-cell (CAR-T) immunotherapy.
Contract Research & Services > Contract Research > News
Teva, University College London start brain imaging study to treat neurodegenerative diseases
By PBR Staff Writer
Teva Pharmaceutical Industries and University College London (UCL) have started a brain-imaging study to uncover a new approach in neurodegenerative disease.
Contract Research & Services > Contract Research > News
Ipsen, Interprotein partner to develop new therapeutic peptides in endocrinology
By PBR Staff Writer
Ipsen and Interprotein have partnered to develop and commercialize new therapeutic peptides in endocrinology.
Contract Research & Services > Contract Research > News
Turing Pharmaceuticals inks research deal with University of Toledo for canavan disease
Turing Pharmaceuticals has signed a sponsored research agreement with the University of Toledo to discover and develop new treatments for Canavan Disease.
Contract Research & Services > Contract Research > News
Cerulean, AstraZeneca and NCI to assess efficacy of CRLX101 and Lynparza combination
By PBR Staff Writer
Cerulean Pharma, AstraZeneca and the National Cancer Institute (NCI) have agreed to collaborate on a clinical study to assess the combination of CRLX101 and Lynparza (olaparib) in patients with small cell lung cancer.
Contract Research & Services > Contract Research > News
ImmunoCellular signs sponsored research deal with University of Texas MD Anderson Cancer
ImmunoCellular Therapeutics has entered into a sponsored research agreement with Dr. Cassian Yee at the University of Texas MD Anderson Cancer Center.
Contract Research & Services > Contract Research > News
Beckman Coulter, IncellDx sign distribution deal for human papilloma virus research
Beckman Coulter Life Sciences and IncellDx have signed a distribution agreement which focuses exclusively on clinical researchers in mainland China, Hong Kong and Taiwan working on the Human Papilloma Virus (HPV) and cancer.
Contract Research & Services > Contract Research > News
Hanmi inks license agreement with Janssen
By PBR Staff Writer
South Korea-based Hanmi Pharmaceutical has signed a license agreement with Janssen Pharmaceuticals to develop a new diabetes and obesity drug.
Contract Research & Services > Contract Research > News
Ignyta buys rights to taladegib oncology program from Eli Lilly
By PBR Staff Writer
Ignyta has secured an exclusive global license to Eli Lilly and Company's taladegib, an orally available small molecule hedgehog/smoothened antagonist under development to treat a range of cancers.
Contract Research & Services > Contract Research > News
CytomX, MD Anderson Cancer Center partner for probody-enabled CAR-NK cell therapies
CytomX Therapeutics has entered into a collaboration with the University of Texas MD Anderson Cancer Center to research Probody-enabled chimeric antigen receptor natural killer (CAR-NK) cell therapies, to be known as ProCAR-NK cell therapies.
Contract Research & Services > Contract Research > News
106-120 of 2107 results